Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Patent
1994-10-31
1999-10-19
Scheiner, Laurie
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Amino acid sequence disclosed in whole or in part; or...
4242081, 530300, 530350, 435 5, A61K 3921, A61K 3800, C07K 100
Patent
active
059685140
ABSTRACT:
The human immunodeficiency virus (HIV) contains, in addition to the canonical genes gag, pol, and env, an open reading frame in the 3' region of the genome that overlaps with the 3' long terminal repeat (LTR). Initial studies on the protein encoded by this ORF revealed a negative effect on HIV replication in vitro and this gene product was subsequently designated the negative factor, or Nef. The nef gene product is 25-29 kDa protein that localizes primarily to the cytoplasm of HIV-infected cells. The subject of this invention pertains to the discovery of a superantigen activity associated with this peptide and peptidic fragments derived therefrom. Superantigens are powerful T-cell mitogens that bind directly to major histocompatibility complex (MHC) class II molecules and form a binary complex with the variable .beta. (V.sub..beta.) region of the T-cell antigen receptor (TCR). It was demonstrated that Nef induces the rapid proliferation of human peripheral mononuclear cells and T-lymphocyte cytokine production. Nef peptidic fragments were also identified that display major histocompatibility complex (MHC) class II binding activity. These peptides can be utilized to generate suitable immune responses in the desired host.
REFERENCES:
patent: 5221610 (1993-06-01), Montagnier et al.
Held, B.W. et al. (1992) "An Exogenous Mouse Mammary Tumor Virus with Properties of Mls-1.sup.a (Mtv-7)" J. Exp. Med. 175:1623-1633.
Choi, T. et al. (1991) "A superantigen encoded in the open reading fram of the 3' long terminal repeat of mouse mammary tumour virus" Bature 350(6315):203-205.
Acha-Orbea H. et al. (1991) "Clonal deletion of V.beta.14-bearing T cells in mice transgenic for mammary tumour virus" Nature 350(6315):207-209.
Korman, A.J. et al. (1992) "The mouse mammary tumour virus long terminal repeat encodes a type II transmembrane glycoprotein" The EMBO Journal 11(5):1901-1905.
Torres, B.A. et al. (1993) "Bacterial and Retroviral superantigens share a common region on class II MHC antigens" The Journal of Immunology, Abstracts Part II, p. 287A, abstract No. 1642.
O'Neill, H.C., C. Jolly (1992) "Retroviral superantigens" Immunology Today 13(11):462-463.
Acha-Orbea, H. (1993) "Superantigens Expressed by Mouse mammary Tumor Virus" Current Communications in Cellular and Molecular Biology 7:31-44.
Cernescu, C., S. Ruta (1992) "Biological roles of HIV Nef proteins" Rev. Roum. Virol. 43:95-100.
Sabatier, J.-M. et al. (1990) "Large fragments of nef-protein and gp110 envelope glycoprotein from HIV-1" Int. J. Peptide Protein Res. 35:63-72.
Choppin, J. et al. (1991) "HLA-Binding Regions of HIV-1 Proteins" The Journal of Immunology 147(2):569-574.
Kotzin B. et al., Superantigens and their porential role in human disease, Adv Immunol. 54:99-166, 1993.
Gallo et al., 1988, "HIV/HTLV gene nomenclature," Nature 333:514.
Laurence, J., 1988 "Update: HIV-1 Gene Nomenclature," AIDS Res. Human Retro. 4:vii-viii.
1998, "Instructions to Authors", J. Virol. 72(1):x-xi.
Johnson Howard M.
Torres Barbara A.
Yamamoto Janet K.
Parkin Jeffrey S.
Scheiner Laurie
University of Florida
LandOfFree
Methods for stimulating immune responses in a host through the a does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for stimulating immune responses in a host through the a, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for stimulating immune responses in a host through the a will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2052151